Clinical Trial Update: Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of indacaterol in healthy subjects and individuals with hepatic impairment completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED